Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
NCT04814420
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove the presence of atrial fibrosis on Delayed Enhancement Magnetic Resonance Imaging (DE-MRI) in OSA patients without atrial fibrillation (AF).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Atrial Fibrillation
- Obstructive Sleep Apnea
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Tulane University
- Last updated on ClinicalTrials.gov
- June 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Louisiana · 3
- East Jefferson General Hospital · New Orleans, LA
- Tulane Doctors - Speciality Care - Napoleon · New Orleans, LA
- University Medical Center · New Orleans, LA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.